Haibo Yu

机构：Guangzhou University of Chinese Medicine, Jiamusi University, North China Electric Power University, Okayama University, Zhengzhou University, Wenzhou Central Hospital, First Affiliated Hospital of Jiamusi University, Second Hospital of Tianjin Medical University, Zhengzhou People's Hospital, Shenzhen Pingle Orthopedic Hospital, Fourth People's Hospital of Shenzhen, Tianjin Medical University, Harbin Veterinary Research Institute, Chongqing Medical University · ORCID：0009-0003-0136-4762

发表论文 125 篇 · 总被引 2332 次 · h-index 26

代表论文

• HOXA‐AS2 Epigenetically Inhibits HBV Transcription by Recruiting the MTA1‐HDAC1/2 Deacetylase Complex to cccDNA Minichromosome (2024 · Advanced Science · 被引 14)
• Preconditioning with acteoside ameliorates myocardial ischemia‑reperfusion injury by targeting HSP90AA1 and the PI3K/Akt signaling pathway (2025 · Molecular Medicine Reports · 被引 8)
• Asiatic acid inhibits HBV cccDNA transcription by promoting HBx degradation (2024 · Virology Journal · 被引 7)
• Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SCs) through the Galectin-9-Dependent Mechanism (2024 · International Journal of Molecular Sciences · 被引 7)
• Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications (2024 · OncoTargets and Therapy · 被引 7)
• Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinoma (2025 · Scientific Reports · 被引 6)